Immunohistochemical study of basic fibroblast growth factor and vascular endothelial growth factor expression for age determination of cutaneous wounds

被引:46
作者
Takamiya, M [1 ]
Saigusa, K [1 ]
Aoki, Y [1 ]
机构
[1] Iwate Med Univ, Sch Med, Dept Legal Med, Morioka, Iwate 0208505, Japan
关键词
basic fibroblast growth factor; vascular endothelial growth factor; skin; wound healing; immunohistochemistry; aging of wounds;
D O I
10.1097/00000433-200209000-00012
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
The authors investigated the expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) during skin wound healing using immunohistochemical techniques. After a full-thickness incision was made on the dorsal skin, mice were killed 0.5, 1, 3, 8, 24, 72, 144, or 240 hours after incision, and the wound was excised. To evaluate the influences of postmortem degeneration, cutaneous wound excision was performed I to 5 days after the mice were killed. The excised wounds were stained by the conventional streptoavidin-biotinylated peroxidase complex method, using specific antibodies, and the ratio of the number of positive cells to total cells was determined. Expression of bFGF was detected in the nuclei of epidermal cells and fibroblasts in the early 0.5- to 1-hour phases and the late 24- to 144-hour phases. Expression of VEGF was detected in the cytoplasm of epidermal cells in the 24- to 144-hour phases. Immunoreactivity of both cytokines was detected I day post mortem and was especially well preserved in the fibroblasts. Time-dependent expression of both factors suggested that they would be useful markers for the determination of wound age. However, bFGF should be superior to VEGF because of its earlier expression and because of its more persistent expression in dermal fibroblasts with increasing postmortem interval.
引用
收藏
页码:264 / 267
页数:4
相关论文
共 24 条
[1]   SYNERGISTIC EFFECT OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR ON ANGIOGENESIS IN-VIVO [J].
ASAHARA, T ;
BAUTERS, C ;
ZHENG, LP ;
TAKESHITA, S ;
BUNTING, S ;
FERRARA, N ;
SYMES, JF ;
ISNER, JM .
CIRCULATION, 1995, 92 (09) :365-371
[2]  
Brown KJ, 1996, LAB INVEST, V75, P539
[3]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[4]   Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements in the bFGF promoter [J].
Faris, M ;
Ensoli, B ;
Kokot, N ;
Nel, AE .
AIDS, 1998, 12 (01) :19-27
[5]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[6]   Role of vascular endothelial growth factor in the regulation of angiogenesis [J].
Ferrara, N .
KIDNEY INTERNATIONAL, 1999, 56 (03) :794-814
[7]   MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS [J].
FERRARA, N ;
HOUCK, K ;
JAKEMAN, L ;
LEUNG, DW .
ENDOCRINE REVIEWS, 1992, 13 (01) :18-32
[8]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF FIBROBLAST GROWTH-FACTOR, AN ANGIOGENIC FACTOR WHICH ALSO CONTROLS THE PROLIFERATION AND DIFFERENTIATION OF MESODERM AND NEUROECTODERM DERIVED CELLS [J].
GOSPODAROWICZ, D ;
NEUFELD, G ;
SCHWEIGERER, L .
CELL DIFFERENTIATION, 1986, 19 (01) :1-17
[9]  
GOTO F, 1993, LAB INVEST, V69, P508
[10]  
GREGORY J, 1991, BIOCHEM BIOPH RES CO, V180, P572